Transcription Factors in Autoimmune Diseases
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
2787-2796
Author(s):
Martin Eggert, Andreas Kluter, Uwe K. Zettl and Gunther Neeck
Immunomodulatory Activities of Glucocorticoids: Insights from Transgenesis and Gene Targeting
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
2797-2805
Author(s):
H. M. Reichardt
Negative Glucocorticoid Receptor Response Elements and their Role in Glucocorticoid Action
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
2807-2816
Author(s):
Dostert A. and Heinzel T.
Novel Ligands: Fine Tuning the Transcriptional Activity of the Glucocorticoid Receptor
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
2817-2826
Author(s):
M. Schulz and M. Eggert
The NF-kB Pathway as a Potential Target for Autoimmune Disease Therapy
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
2827-2837
Author(s):
Susanne Bacher and M. Lienhard Schmitz
The Role of STATs in Inflammation and Inflammatory Diseases
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
2839-2850
Author(s):
E. Pfitzner, S. Kliem, D. Baus and M. C. Litterst
Nuclear Architecture and Gene Expression in the Quest for Novel Therapeutics
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
2851-2860
Author(s):
Frank O. Fackelmayer
Pituitary Adenylate Cyclase Activating Polypeptide: A Potential Neuroprotective Peptide
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
2861-2889
Author(s):
Aniko Somogyvari-Vigh and Dora Reglodi
Antimicrobial Peptides: Mediators of Innate Immunity as Templates for the Development of Novel Anti-Infective and Immune Therapeutics
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
2891-2905
Author(s):
P. S. Hiemstra, B. A. Fernie-King, J. McMichael, P. J. Lachmann and J.- M. Sallenave
Leishmaniasis: Current Status of Vaccine Development
Journal:
Current Molecular Medicine
Volume:
4
Page:
667-679
Author(s):
Bindu Sukumaran and Rentala Madhubala